"10.1371_journal.pone.0121364","plos one","2015-03-16T00:00:00Z","Nuria Gresa-Arribas; Helena Ariño; Eugenia Martínez-Hernández; Mar Petit-Pedrol; Lidia Sabater; Albert Saiz; Josep Dalmau; Francesc Graus","Neuroimmunology Program, Institut d’Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Service of Neurology, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain; Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: NGA HA LS AS JD FG. Performed the experiments: NGA HA EMH MPP LS. Analyzed the data: NGA HA JD FG. Contributed reagents/materials/analysis tools: NGA HA EMH MPP LS AS JD FG. Wrote the paper: NGA HA JD FG.","Dr. Dalmau has a research grant from Euroimmun, and receives royalties from patents for the use of the patent concerning anti-Ma antibodies (Patent Number: US 6,387,639; Issued May 14th, 2002. Licensed to Athena Diagnostics, USA) and the one for NMDAR antibodies (Patent Name: NMDAR test; USA Patent Number: US 7,972,796; Issued July 5th, 2011. Licensed to Euroimmun, Inc, Germany. Europe patent number: EP 2 057 466). The other authors report no disclosures. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","03","Nuria Gresa-Arribas","NGA",8,TRUE,6,5,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
